Phase I Study of Functionally Enhanced CD33 CAR T Cells in Patients with Relapsed or Refractory Acute Myeloid Leukemia.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined